Skip to main content
. 2021 Aug 15;18(3):693–704. doi: 10.20892/j.issn.2095-3941.2020.0262

Figure 1.

Figure 1

DDX5 mRNA and protein expression in patients with hepatocellular carcinoma (HCC) and its prognostic significance. (A) Relative expression of DDX5 mRNA in HCC using The Cancer Genome Atlas database from 371 HCC tissues compared to 50 non-neoplastic liver tissues; P < 0.001. (B) DDX5 and HSP90 protein expressions in HCC tissues (T) and surrounding non-neoplastic area (NT) detected by Western blot; *P < 0.05; ***P < 0.001. (C) Immunohistochemistry of DDX5 from HCC and non-neoplastic tissues (Scale bar: 100 μm). (D) The mRNA level of DDX5 in HCC surgical specimens detected by qRT-PCR (mean ± SEM, n = 24, P = 0.008). (E) The incidence of HCC recurrence after resection stratified by baseline DDX5 expressions in tumor tissues (cut-off value, T/NT= 1, n = 24, P = 0.04).